化学信息:
化学名 | N-[(2S,3R)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-[2-[4-(morpholin-4-ylmethyl)phenyl]ethynyl]benzamide | |
简称 | CHIR-090 | |
别名 |
CHIR 090, CHIR090 |
|
中文名 | N/A | |
化学式 | C24H27N3O5 | |
分子量 | 437.49 | |
CAS号 | 728865-23-4 | |
纯度 | 98% | |
溶剂/溶解度 |
Water<1mg/ml; DMSO30mg/ml; Ethanol<1mg/ml |
|
溶液配制 | 5mg加入1.14ml DMSO,或者每4.37mg加入1ml DMSO,配制成10mM溶液。SC3296-10mM用DMSO配制。 |
生物信息:
产品描述 | CHIR-090 is a potent LpxC inhibitor, displays two-step time-dependent inhibition and kills a wide range of Gram-negative pathogens as effectively as ciprofloxacin or tobramycin. | ||||
信号通路 | Anti-infection | ||||
靶点 | LpxC | - | - | - | - |
IC50 | - | - | - | - | - |
体外研究 | The UDP-3-O-(R-3-hydroxyacyl)-N-acetylglucosamine deacetylase LpxC is an essential enzyme of lipid A biosynthesis in Gram-negative bacteria and a promising antibiotic target. | ||||
体内研究 | N/A | ||||
临床实验 | N/A | ||||
特征 | N/A |
相关实验数据(此数据来自于公开文献,碧云天并不保证其有效性):
酶活性检测实验 | |
方法 | N/A |
细胞实验 | |
细胞系 | N/A |
浓度 | N/A |
处理时间 | N/A |
方法 | N/A |
动物实验 | |
动物模型 | N/A |
配制 | N/A |
剂量 | N/A |
给药方式 | N/A |
产品编号 | 产品名称 | 包装 |
SC3296-10mM | CHIR-090 (LpxC抑制剂) | 10mM×0.2ml |
SC3296-5mg | CHIR-090 (LpxC抑制剂) | 5mg |
SC3296-25mg | CHIR-090 (LpxC抑制剂) | 25mg |
— | 说明书 | 1份 |
保存条件:
-20℃保存,至少一年有效。5mg和25mg包装也可室温保存,至少6个月有效。如果溶于非DMSO溶剂,建议分装后-80℃保存,预计6个月内有效。
产品编号
|
产品名称
|
产品包装
|
SC1000-10mM
|
Ibrutinib (BTK抑制剂)
|
10mM
|
SC1000-5mg
|
Ibrutinib (BTK抑制剂)
|
5mg
|
SC1000-25mg
|
Ibrutinib (BTK抑制剂)
|
25mg
|
SC1018-10mM
|
R406 (Syk抑制剂)
|
10mM
|
SC1018-5mg
|
R406 (Syk抑制剂)
|
5mg
|
SC1018-25mg
|
R406 (Syk抑制剂)
|
25mg
|
SC1022-10mM
|
R406 (free base)
(Syk抑制剂)
|
10mM
|
SC1022-5mg
|
R406 (free base)
(Syk抑制剂)
|
5mg
|
SC1022-25mg
|
R406 (free base)
(Syk抑制剂)
|
25mg
|
SC1072-10mM
|
ACP-196 (BTK抑制剂)
|
10mM
|
SC1072-5mg
|
ACP-196 (BTK抑制剂)
|
5mg
|
SC1072-25mg
|
ACP-196 (BTK抑制剂)
|
25mg
|
SC1139-10mM
|
AVL292 (BTK抑制剂)
|
10mM
|
SC1139-5mg
|
AVL292 (BTK抑制剂)
|
5mg
|
SC1139-25mg
|
AVL292 (BTK抑制剂)
|
25mg
|
SC1144-10mM
|
RN486 (BTK抑制剂)
|
10mM
|
SC1144-5mg
|
RN486 (BTK抑制剂)
|
5mg
|
SC1144-25mg
|
RN486 (BTK抑制剂)
|
25mg
|
SC1148-10mM
|
Entospletinib
(Syk抑制剂)
|
10mM
|
SC1148-5mg
|
Entospletinib
(Syk抑制剂)
|
5mg
|
SC1148-25mg
|
Entospletinib
(Syk抑制剂)
|
25mg
|
SC1153-10mM
|
ONO-4059 analogue
(BTK抑制剂)
|
10mM
|
SC1153-5mg
|
ONO-4059 analogue
(BTK抑制剂)
|
5mg
|
SC1153-25mg
|
ONO-4059 analogue
(BTK抑制剂)
|
25mg
|
SC1166-10mM
|
PRT062607 HCl
(Syk抑制剂)
|
10mM
|
SC1166-5mg
|
PRT062607 HCl
(Syk抑制剂)
|
5mg
|
SC1166-25mg
|
PRT062607 HCl
(Syk抑制剂)
|
25mg
|
SC1184-10mM
|
CGI-1746 (BTK抑制剂)
|
10mM
|
SC1184-5mg
|
CGI-1746 (BTK抑制剂)
|
5mg
|
SC1184-25mg
|
CGI-1746 (BTK抑制剂)
|
25mg
|
SC1202-10mM
|
CNX-774 (BTK抑制剂)
|
10mM
|
SC1202-5mg
|
CNX-774 (BTK抑制剂)
|
5mg
|
SC1202-25mg
|
CNX-774 (BTK抑制剂)
|
25mg
|
SC3296-10mM
|
CHIR-090 (LpxC抑制剂)
|
10mM
|
SC3296-5mg
|
CHIR-090 (LpxC抑制剂)
|
5mg
|
SC3296-25mg
|
CHIR-090 (LpxC抑制剂)
|
25mg
|